Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 22 EP applications Filip Gerard Verberckmoes has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12766452

IMPROVED PROCESS FOR PREPARING 2-[(2E)-2-FLUORO-2-(3-PIPERIDINYLIDENE)ETHYL]-1H-ISOINDOLE-1,3(2H)-DIONE

IPC classification:
C07D 211/70, C07D 401/04, C07F 9/24
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13702653

METHOD TO PREVENT DEACTIVATION OF METAL CATALYSTS IN CATALYTIC POLYMERISATION PROCESSES

IPC classification:
A01N 43/40, C08F 2/44, C08F 4/42, C09D 5/16
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13707638

USE OF TRALOPYRIL AGAINST MARINE WOODBORERS

IPC classification:
A01N 25/02, A01N 43/36, A01P 9/00, B27K 3/34
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP11796711

IMIDAZOPYRIDINES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 471/04, C07D 487/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11799682

AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13728403

4 - SUBSTITUTED 1, 3 - DIHYDRO - 2H - BENZIMIDAZOL - 2 - ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61P 11/00, C07D 235/20, C07D 235/26, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13730845

1,3 -DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61P 31/12, C07D 403/06, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728749

1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61K 31/4709, A61P 11/00, A61P 31/12, C07D 413/14, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728404

1,3 -DIHYDRO- 2H-BENZIMIDAZOL- 2 -ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61P 31/12, C07D 403/14, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14701389

QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
C07D 403/06, C07D 403/14, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11794793

INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 403/06, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14744362

SUBSTITUTED PYRIDINE-PIPERAZINYL ANALOGUES AS RSV ANTIVIRAL COMPOUNDS

IPC classification:
C07D 403/04, C07D 403/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP15193770

SYNERGISTIC IMAZALIL COMBINATIONS

IPC classification:
A01N 43/50, A01N 57/12, A01P 3/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP16155033

BIOCIDAL COMPOSITION COMPRISING A THIOL GROUP MODULATING ENZYME INHIBITOR AND PYRION COMPOUND

IPC classification:
A01N 43/40, A01N 47/14, A01N 59/16, A01P 1/00, A01P 3/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Johnson & Johnson
Status:
EXAMINATION REQUESTED
EP11728629

ANTIMICROBIAL COMBINATIONS OF PYRION COMPOUNDS WITH POLYETHYLENEIMINES

IPC classification:
A01N 43/40, A01P 1/00, A61K 31/44, A61K 31/785, A61L 2/18, B27K 3/50, C02F 1/50, C10M 161/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11794794

AZABENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11802054

BENZIMIDAZOLE RESPIRATORY SYNCYTIAL VIRUS INHIBITORS

IPC classification:
A61K 31/4188, A61P 11/00, C07D 235/26, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15714532

SPIRO UREA COMPOUNDS AS RSV ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/407, A61K 31/4184, A61K 31/437, A61P 31/14, C07D 487/10
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15771593

MONO- OR DI-SUBSTITUTED INDOLES AS DENGUE VIRAL REPLICATION INHIBITORS

IPC classification:
A61K 31/404, A61P 31/12, C07D 209/42
Applicant:
Katholieke Universiteit Leuven
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15771136

MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS

IPC classification:
A61K 31/404, A61P 31/12, C07D 209/42
Applicant:
Katholieke Universiteit Leuven
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15804835

PIPERIDINE SUBSTITUTED TRICYCLIC PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES WITH INHIBITORY ACTIVITY ON THE REPLICATION OF THE RESPIRATORY SYNCYTIAL VIRUS (RSV)

IPC classification:
A61K 31/519, A61P 31/14, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15804823

PIPERIDINE SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES WITH INHIBITORY ACTIVITY ON THE REPLICATION OF THE RESPIRATORY SYNCYTIAL VIRUS (RSV)

IPC classification:
A61K 31/519, A61P 31/14, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
Request for examination was made

Please Sign in to use this feature